Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000800168 | SCV000939868 | uncertain significance | Alzheimer disease | 2024-12-02 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 364 of the APP protein (p.Leu364Phe). This variant is present in population databases (rs749453173, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with APP-related conditions. ClinVar contains an entry for this variant (Variation ID: 645976). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Hudson |
RCV001090099 | SCV001245563 | uncertain significance | Primary degenerative dementia of the Alzheimer type, presenile onset | 2019-10-28 | criteria provided, single submitter | research |